Liquid Biopsy Market Key Highlights and Future Opportunities Till 2035

The global liquid biopsy market is poised for substantial growth, with its size projected to increase from USD 6.09 billion in 2024 to USD 29.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 15.53% during this period. This growth is primarily driven by the rising demand for non-invasive liquid biopsy products, fueled by an increasing focus on early cancer detection and patient monitoring.

Cancer remains a critical global health challenge, being the second leading cause of death worldwide. The World Health Organization estimates approximately 16.3 million cancer-related deaths by 2040. Among cancer types, breast cancer is the most common globally, followed by lung, colorectal, and prostate cancers. Early detection is crucial for improving treatment success and patient survival rates.

Read More :- https://www.rootsanalysis.com/....reports/liquid-biops